Venrock Adviser, LLC
Source: SEC Form 13F · as of Mar 2026Venrock Adviser, LLC holds 8 biotech & pharma companies tracked by BioSniper, totaling $327.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
8
Total value held
$327.5M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Dianthus Therapeutics, Inc. /DE/ (DNTH)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| DNTHDianthus Therapeutics, Inc. /DE/ | 1,180,000 | $99.0M |
| COGTCogent Biosciences, Inc. | 2,000,000 | $77.0M |
| ELVNEnliven Therapeutics, Inc. | 1,726,331 | $67.7M |
| DYNDyne Therapeutics, Inc. | 2,173,913 | $39.4M |
| CGEMCullinan Therapeutics, Inc. | 1,379,965 | $19.6M |
| SEPNSepterna, Inc. | 506,056 | $12.2M |
| ANROAlto Neuroscience, Inc. | 500,000 | $11.2M |
| XFORX4 Pharmaceuticals, Inc | 330,525 | $1.4M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.